A simple DNA test using circulating tumour DNA could forecast how advanced breast cancer responds to treatment, enabling earlier switches to options more likely to work,...
The Femtech World Awards are set to recognise the people, organisations and innovations revolutionising how we treat and diagnose cancer in women. Now in its third...
Chemotherapy may reduce ovarian function and fertility in women, a recent study suggests. The research examined how cancer treatment affects ovarian tissue, hormone production and ovarian...
The Magtrace lymphatic tracer has become the latest Endomag device to receive EU Medical Device Regulation (EU MDR) certification, marking the final step in securing approval...
Researchers have identified a potential treatment target for triple-negative breast cancer, the most aggressive form of breast cancer. The study found that PUF60 helps cancer cells...
The National Institute for Health and Care Excellence (NICE) has proposed age-based thresholds for ovarian cancer screening to help identify women at higher risk earlier. Previously,...
Analysis of fluid flushed through a fallopian tube holds promise for providing insights into molecular changes linked to early ovarian cancer development, new research has revealed....
Megestrol, a hot flush drug for breast cancer patients, may also curb tumours when added to standard hormone therapy, an early trial has found. The PIONEER...
A combination of THC and CBD derived from cannabis was shown to kill ovarian cancer cells without harming healthy cells in laboratory studies. The findings suggest...
HRT (hormone replacement therapy) may not increase breast cancer risk in women with BRCA mutations, new research suggests. Women who inherit harmful mutations in the BRCA1...
